Malignant Pleural Effusions | A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis

Malignant Pleural Effusions research study

What is the primary objective of this study?

Pleurodesis is a technique used to fuse the two layers of the lining over the lung. This is done to get rid of collections of fluid or air in this space. A common reason would be cancer of the underlying lung or elsewhere causing fluid to collect in the pleural space. In this situation it is a palliative procedure to free the patient from symptoms like breathlessness.

Who is eligible to participate?

Inclusion Criteria: - Age over 12 years - Symptomatic recurrent pleural effusion - Pneumothorax needing pleurodesis Exclusion Criteria: - Life expectancy <1 month - Unwilling to give consent - Empyema - ICTD drain output >150 ml/d - Presence of an airleak

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Malignant Pleural Effusions

Recurrent Pleural Effusions

Primary Spontaneous Pneumothorax

Secondary Spontaneous Pneumothorax

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Procedure:Pleurodesis with either talc or iodopovidone

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Study Status

Unknown status

Start Date: January 2006

Completed Date: December 2007

Phase: N/A

Type: Interventional


Primary Outcome: Success

Secondary Outcome: Death

Study sponsors, principal investigator, and references

Principal Investigator: Dheeraj Gupta, MD, DM, FCCP

Lead Sponsor: Postgraduate Institute of Medical Education and Research


More information:

Discuss Pneumothorax